Antiproliferative efficacy of Tabernaemontana divaricata against HEP2 cell line and Vero cell line

ABSTRACT

Background: Laryngeal cancer may also be called cancer of the larynx or laryngeal carcinoma. Conventional plants are a precious source of novel anticancer agents and are still in performance better role in health concern. The study was intended to estimation of the anticancer activity of the chloroformic extract of Tabernaemontana divaricata on the human epidermoid larynx carcinoma cell line (Hep 2). Materials and Methods: The aerial parts (leaves, stem, and flowers) of T. divaricata were tested for its inhibitory effect in 96 microplate formats against Hep 2 cell line. The anticancer activity of samples on Hep 2 and Vero was determined by the 3‑(4,5‑dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide assay and various enzymatic parameters like catalase, reduced glutathione (GSH), GSH peroxidase, and superoxide anion scavenging activity. Viable cells were determined by the absorbance at 540 nm. Measurements were performed, and the concentration required for a 50% inhibition of viability (IC50) was determined graphically. The effect of the samples on the proliferation of Hep 2 and Vero cells was expressed as the % cell viability. Results: The extract on Hep 2 cell line up to 7.8 µg/ml and that IC50 value on Hep 2 cell line was 112 µg whereas 94 µg for Vero cell line. Hence, T. divaricata has lesser significant action on Vero cell line. Conclusion: Medicinal plant drug discovery continues to provide new and important leads against various pharmacological targets including cancer. Our results clearly indicate the anticancer property of the medicinal plant T. divaricata against the human laryngeal carcinoma cell lines (Hep 2 cell line).

KEYWORDS

• Hep2 cell lines
• laryngeal carcinoma
• 3-(4
• 5‑dimethylthiazol-2-yl)-2
• 5-diphenyltetrazolium bromide assay
• Tabernaemontana divaricata
• Vero cell lines A B S T R A C T

Showing references and in-text citations exactly as published.

• DOI10.4103/0973-1296.157682Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 11, ISSUE 42SS1 Cytotoxic glucosphingolipid from Celtis AfricanaShagufta Perveen, Areej Mohammad Al‑Taweel, Ghada Ahmed Fawzy, Azza Muhammed El‑Shafae, Afsar Khan, Peter Proksch · pp. 1–5Original ArticleSame type: Article
• Article · VOLUME 11, ISSUE 42SCytotoxicity of some edible mushrooms extracts over liver hepatocellular carcinoma cells in conjunction with their antioxidant and antibacterial propertiesGökhan Sadi, Buğrahan Emsen, Abdullah Kaya, Aytaç Kocabaş, Seval Çınar, Deniz İrtem Kartal · pp. 6–18Original ArticleSame type: Article
• Article · VOLUME 11, ISSUE 42SS19 Pharmacophore modeling, in silico screening, molecular docking and molecular dynamics approaches for potential alpha‑delta bungarotoxin‑4 inhibitors discoveryR. Barani Kumar, M. Xavier Suresh, B. Shanmuga Priya · pp. 19–28Original ArticleSame type: Article
• Article · VOLUME 11, ISSUE 42SS29 Antimutagenic potential of harpagoside and Harpagophytum procumbens against 1‑nitropyreneLuigi Manon, Baghdikian Béatrice, Orsière Thierry, Pompili Jocelyne, Mabrouki Fathi, Ollivier Evelyne · pp. 29–36Original ArticleSame type: Article